2024

"Protein, protein, protein!" Commentary in Nordic Life Science by Group leader Jan Terje Andersen and PRIMA mentor Hanne Mette Dyrlie Kristensen 

Karl-Johan Malmberg and his team receives a KLINBEFORSK grant to launch a clinical phase I program targeting hematological malignancies with adaptive NK cells

Researcher Stian Foss got the Norwegian Society of Immunology prize for the best research article published in 2024 

Get to know Lilly Bay in the Andersen Lab! Lilli started her postdoc position in PRIMA in July, 2024

Get to know Mireia Franco Tolsau in the Olweus Lab! Tolsau is Spanish and started her PhD position in PRIMA in September, 2024

The personal prize of 20 000 NOK was handed out at Solstrand October 22-23 for her recent publication in Nature Medicine “A T cell receptor targeting a recurrent driver mutation in FLT3 mediates elimination of primary human acute myeloid leukemia in vivo”. 

October 10, the whole PRIMA family gathered at Håndverkeren to engage in scientific presentations, discussions, and networking.

Researchers at PRIMA introduce a novel approach to enhancing immune cell efficacy. Their work is published in the prestigious journal Med. in collaboration with the renowned Michel Sadelain group at Memorial Sloan Kettering Cancer Center, pioneers in the field of CAR T cell therapy.

Earlier this year, PRIMA PI and co-director Prof Johanna Olweus received a large Cancer Grand Challenges grant funded by Cancer Research UK and NIH together with a global team “MATCHMAKERS”. Within this team is the Nobel prize winner in chemistry 2024 David Baker who got the prize for his work on computational protein design.

Get to know Nikoline L. Rasmussen in the Andersen lab! Rasmussen is originally Danish, but now a Norwegian citizen after living in Norway for more than 20 years, and she started her postdoc position in PRIMA in August 2024.

Get to know Hannah Cuthbertson Husbyn in the Malmberg Lab! Husbyn is half Norwegian/half Scottish and started her PhD position in PRIMA in August, 2024

Get to know Madeleine Lehander in the Olweus Lab! Lehander is from Sweden and started her postdoc position in PRIMA in September, 2024

A warm welcome to our three new associated group leaders: Geir Kjetil Sandve, Johanne Jacobsen and Victor Greiff. We believe PRIMA will benefit greatly from the competency they bring into PRIMA and we look forward to excellent collaboration and synergy. Read more about them below.

Postdoc Fulgencio Ruso-Julve received a PRIMA Synergy grant to establish protocols for mapping of human Fc receptors in the tumor microenvironment

Postdocs Nicholas Chandler and Lamberto Torralba-Raga received a PRIMA Synergy grant to develop a novel immunoreceptor system for use in cancer immunotherapy

Researcher Hassen Kared received a PRIMA Synergy grant to study the T cell subsets in the tumor microenvironment in prostate cancer

"Pan-cancer profiling of tumor-infiltrating natural killer cells through transcriptional reference mapping" was published in the high ranked journal Nature Immunology July 2. This work will be an important resource when designing new NK cell therapies.

Three Oslo University Hospital scientists received prestigous awards for their outstanding research on Friday June 14th. Among these, PRIMA researcher Chloe B. Steen.

Civitan Norway's research fund supports Andersen's team to test novel approaches to target the proteins responsible for Alzheimer's disease

VG news story: Creates new medicines with super-powers

Mark Cragg from the University of Southampton, Visiting Professor at PRIMA, is visiting the Centre Aug 26-29th

Antibody candidate developed with new technology from Jan Terje Andersen's group is now in clinical trial to test the safety in healthy participants

"Engineering immune-evasive allogeneic cellular immunotherapies"

PRIMA Synergy grant project leader Postdoc Lamberto Torralba-Raga has been awarded 100 000 USD for his cell engineering project.

Get to know Pegah Nammian in Lund-Johansen lab! Pegah started her work in PRIMA in March 2024